BMEA - Biomea Fusion Inc
Biomea Fusion Inc Logo

BMEA - Biomea Fusion Inc

https://biomeafusion.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company is headquartered in Redwood City, California.

52W High
$13.07
52W Low
$1.29

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.15
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-3.75
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
4.15
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
9.47%
Institutions (25–75% balanced)
48.40%
Shares Outstanding
59,508,000
Float
47,423,500
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-3.00
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-1.71%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.0472
Previous
0.0371
Trend
Rising
Signal Cross
No cross

As of
Sep. 11, 2025